DDDRX
Price
$15.45
Change
+$0.01 (+0.06%)
Updated
Aug 7 closing price
Net Assets
834.45M
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

DDDRX vs RLBCX

Header iconDDDRX vs RLBCX Comparison
Open Charts DDDRX vs RLBCXBanner chart's image
Macquarie Wealth Builder R
Price$15.45
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets834.45M
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
DDDRX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DDDRX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDRX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. DDDRX (834M). RLBCX pays higher dividends than DDDRX: RLBCX (1.56) vs DDDRX (1.21). DDDRX was incepted earlier than RLBCX: DDDRX (22 years) vs RLBCX (23 years). DDDRX (1.34) is less costly to investors than RLBCX (0.89). DDDRX is a more actively managed with annual turnover of: 66.00 vs. RLBCX (44.00). DDDRX has a lower initial minimum investment than RLBCX: DDDRX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 11.04 vs. DDDRX (6.33). RLBCX return over 5 years is better than : 34.79 vs. DDDRX (26.99).
DDDRXRLBCXDDDRX / RLBCX
Total Expense Ratio1.310.89147%
Annual Report Gross Expense Ratio1.340.89151%
Fund Existence22 years23 years-
Gain YTD5.7048.35968%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets834M253B0%
Annual Yield % from dividends1.211.5678%
Returns for 1 year6.3311.0457%
Returns for 3 years13.1729.8444%
Returns for 5 years26.9934.7978%
Returns for 10 years31.7060.6552%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAWN6.030.23
+3.97%
Day One Biopharmaceuticals
HELE21.99-0.23
-1.04%
Helen of Troy Limited
FDS386.67-5.24
-1.34%
Factset Research Systems
ASTC5.35-0.25
-4.47%
Astrotech Corp
MSPR0.74-0.08
-10.14%
MSP Recovery Inc